Evidence map›Paper›PMID 30073600›Full record

ArticleAnnals of surgical oncology2018

Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?

Matthew C Perez, Felipe R de Pinho, Amanda Holstein, Daniel E Oliver, Syeda M H Naqvi, Youngchul Kim, Jane L Messina, Erin Burke, Ricardo J Gonzalez, Amod A Sarnaik and 5 more

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Merkel Cell Carcinoma.Biomedicines · 2021
    Review
  13. Current concepts and approaches to merkel cell carcinoma.Archives of dermatological research · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Patterns of Metastasis in Merkel Cell Carcinoma.Annals of surgical oncology · 2021
    Article
  19. Review
  20. Merkel cell carcinoma: A series of seven cases.Archives of plastic surgery · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Matthew C PerezDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Felipe R de PinhoDepartment of Oncology, Hospital Moinhos de Vento, Porto Alegre, Brazil.
Amanda HolsteinDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Daniel E OliverDepartment of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Syeda M H NaqviDepartment of Biostatistics, Moffitt Cancer Center, Tampa, FL, USA.
Youngchul KimDepartment of Biostatistics, Moffitt Cancer Center, Tampa, FL, USA.
Jane L MessinaDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Erin BurkeDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Ricardo J GonzalezDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Amod A SarnaikDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
C Wayne CruseDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Evan J WuthrickDepartment of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Louis B HarrisonDepartment of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Vernon K SondakDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Jonathan S ZagerDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA. Jonathan.zager@moffitt.org.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
NCI NIH HHS P30 CA076292
6 · The paper itself

Abstract

backgroundGuidelines regarding specific resection margins for primary Merkel cell carcinoma (MCC) are not well established. The current National Comprehensive Cancer Network (NCCN) guidelines recommend 1- to 2-cm resection margins. This study aimed to determine the impact of margin width on local recurrence (LR), disease-specific survival (DSS), overall survival (OS), and type of wound closure.

methodsAll patients who underwent resection of primary MCC at a single institution from 2000 to 2015 were reviewed. Patient demographics, clinicopathologic characteristics, treatments, and outcomes were reviewed.

resultsA total of 240 patients underwent resection of primary MCC with resection margin width identified in the operative report. The median age was 76 years, and 65.8% of the patients were men. Of the 240 patients, 85 (35.4%) had head and neck primaries, 140 (58.3%) had extremity primaries, and 15 (6.3%) had trunk primaries. In terms of margins, 69 patients (28.8%) had a margin of 1 cm, 36 patients (15%) had a margin of 1.1-1.9 cm, and 135 patients (56.2%) had a margin of 2 cm or more. The median follow-up period was 21 months. The LR rate was 2.9% for a margin of 1 cm, 2.8% for a margin of 1.1-1.9 cm, and 5.2% for a margin of 2 cm or more (p = 0.80). The 5-year OS was 63.6% for a margin of 1 cm, 59.7% for a margin of 1.1-1.9, and 70.7% for a margin of 2 cm or more (p = 0.66). The 5-year DSS was 80.3% for a margin of 1 cm, 66.2% for a margin of 1.1-1.9 cm, and 91.8% for a margin of 2 cm or more (p = 0.28). For wound closure, 43.5, 50, and 65.9% of the patients respectively required a flap or graft with a margin of 1, 1.1-1.9, and 2 cm or more (p = 0.006).

conclusionsA 1-cm resection margins did not increase the risk of LR. Margin width did not make a significant difference in DSS or OS. Larger resection margins increase the need for a graft or flap closure.

Indexed as

Margins of ExcisionAdultAgedAged, 80 and overCarcinoma, Merkel CellFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm InvasivenessNeoplasm Recurrence, LocalPrognosisRetrospective StudiesSkin NeoplasmsSurvival Rate

Identifiers

PMID30073600
PMCPMC7771268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.